CD86 and neoplasm: In this study, a computational biology approach was employed to engineer a series of enriched aptamers targeting CTLA-4 and NKG2A receptors on CD8+ T cells and NKG2A receptors on NK cells interactions with B7-1/B7-2 and HLA-E on tumor cells.